Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4 ‐week, double‐blind, randomized, placebo‐controlled phase 2 trial

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - June 5, 2018 Category: Endocrinology Authors: Akira Shimada MD , Toshiaki Hanafusa MD , Atsutaka Yasui PhD , Ganghyuck Lee MSc , Yusuke Taneda MSc , Akiko Sarashina MSc , Kosuke Shiki MSc , Jyothis George MD , Nima Soleymanlou PhD , Jan Marquard MD Source Type: research